Clinical Trial

Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Spinal surgery is generally followed by severe postoperative pain, and poor pain control may cause adverse outcomes such as cardiovascular events, neurocognitive disorders, and chronic postsurgical pain (CPSP). In previous studies, perioperative use of dexmedetomidine or esketamine is each associated with improved analgesia after surgery. Recent studies suggest that combined use of dexmedetomidine and esketamine may produce synergetic effects in improving analgesia. This trial is designed to test the hypothesis that perioperative combined use of dexmedetomidine and esketamine may reduce CPSP in patients after spinal surgery.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-17
Trial Details
NCT Number NCT07525999
Lead Sponsor Peking University First Hospital
Conditions Spinal Surgery, Pain Intensity, Dexmedetomidine, Esketamine, Postoperative Analgesia
Enrollment 274 participants
Start Date 2026-04
Primary Completion 2027-11 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-16